Christian Haslinger
Boehringer Ingelheim (Austria)(AT)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Microtubule and mitosis dynamics, Colorectal Cancer Treatments and Studies, Lung Cancer Treatments and Mutations, HER2/EGFR in Cancer Research
Most-Cited Works
- → Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation(2013)457 cited
- → BI 6727, A Polo-like Kinase Inhibitor with Improved Pharmacokinetic Profile and Broad Antitumor Activity(2009)391 cited
- → p38α suppresses normal and cancer cell proliferation by antagonizing the JNK–c-Jun pathway(2007)354 cited
- → SATB1 Defines the Developmental Context for Gene Silencing by Xist in Lymphoma and Embryonic Cells(2009)186 cited
- → RNA Structures with Pseudo-knots: Graph-theoretical, Combinatorial, and Statistical Properties(1999)111 cited
- → Triple Angiokinase Inhibitor Nintedanib Directly Inhibits Tumor Cell Growth and Induces Tumor Shrinkage via Blocking Oncogenic Receptor Tyrosine Kinases(2017)104 cited
- → A Novel RAF Kinase Inhibitor with DFG-Out–Binding Mode: High Efficacy in BRAF-Mutant Tumor Xenograft Models in the Absence of Normal Tissue Hyperproliferation(2016)91 cited
- → Pharmacological Profile of BI 847325, an Orally Bioavailable, ATP-Competitive Inhibitor of MEK and Aurora Kinases(2016)36 cited
- → Ordino: a visual cancer analysis tool for ranking and exploring genes, cell lines and tissue samples(2019)18 cited
- → Integrative analysis of prostate cancer aggressiveness(2013)17 cited